202 related articles for article (PubMed ID: 34168648)
1. Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV.
Krishnan S; Queiroz ATL; Gupta A; Gupte N; Bisson GP; Kumwenda J; Naidoo K; Mohapi L; Mave V; Mngqibisa R; Lama JR; Hosseinipour MC; Andrade BB; Karakousis PC
Front Immunol; 2021; 12():676980. PubMed ID: 34168648
[TBL] [Abstract][Full Text] [Related]
2. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study.
Zheng Z; Nehl EJ; Zhou C; Li J; Xie Z; Zhou Z; Liang H
BMC Infect Dis; 2020 Nov; 20(1):873. PubMed ID: 33225919
[TBL] [Abstract][Full Text] [Related]
3. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
4. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
[TBL] [Abstract][Full Text] [Related]
5. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
Aemro A; Jember A; Anlay DZ
BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
Dierberg KL; Chaisson RE
Clin Chest Med; 2013 Jun; 34(2):217-28. PubMed ID: 23702172
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Diagnostic Accuracy Study of Abbott RealTi
Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
[TBL] [Abstract][Full Text] [Related]
11. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
12. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy.
Wagh V; Urhekar A; Modi D
Tuberculosis (Edinb); 2017 Jan; 102():24-30. PubMed ID: 28061948
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
14. Identifying quantitative sncRNAs signature using global sequencing as a potential biomarker for tuberculosis diagnosis and their role in regulating host response.
Kaul S; Nair V; Gcanga L; Lakshmanan V; Kalamuddin M; Anang V; Rathore S; Dhawan S; Alam T; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Parihar SP; Khanna A; Malhotra P; Brombacher F; Dasaradhi PV; Guler R; Mohmmed A
Int J Biol Macromol; 2024 Jun; 271(Pt 2):132714. PubMed ID: 38815937
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
Wang C; Yang S; Liu CM; Jiang TT; Chen ZL; Tu HH; Mao LG; Li ZJ; Li JC
Tuberculosis (Edinb); 2018 Jan; 108():26-34. PubMed ID: 29523324
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
18. Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Sekaggya-Wiltshire C; Castelnuovo B; von Braun A; Musaazi J; Muller D; Buzibye A; Gutteck U; Henning L; Ledergerber B; Corti N; Lamorde M; Fehr J; Kambugu A
BMJ Open; 2017 Sep; 7(9):e014679. PubMed ID: 28928173
[TBL] [Abstract][Full Text] [Related]
19. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
